Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365788
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2023-07-11
Brief Title:
Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Organization Data
Organization:
Universitaire Ziekenhuizen KU Leuven
Class:
OTHER
Study ID:
S66466
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Teva Pharma | INDUSTRY |
| Kom Op Tegen Kanker | OTHER |
| Eli Lilly and Company | INDUSTRY |